How many patents does
Osi Pharmaceuticals have?
patents
577
families
102
granted
161
applications
416
US
139
EP
94
WO
70
CN
21
JP
8
KR
7
RoW
238
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Osi Pharmaceuticals
Top ten assignees appearing on patents
2009 - 2018
| osi pharmaceuticals | 479 |
| pfizer products | 24 |
| pfizer | 21 |
| osi pharm | 15 |
| honda, ayako | 6 |
| osi farmas'jutikalz | 4 |
| genentech | 4 |
| aveo pharmaceuticals | 4 |
| prosidion | 3 |
| sgx pharmaceuticals | 2 |
2009
| osi pharmaceuticals | 109 |
| pfizer products | 7 |
| pfizer | 2 |
| sgx pharmaceuticals | 2 |
| osi farmas'jutikalz | 2 |
| beiersdorf | 1 |
| osi pharm | 1 |
| cell pathways | 1 |
| honda, ayako | 1 |
| pfajzer prodakts ink. | 1 |
Osi Pharmaceuticals
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors | 41 | 2004 |
| fused bicyclic mtor inhibitors | 40 | 2005 |
| stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine … 🛈 | 30 | 1999 |
| amino pyrimidine anticancer compounds | 26 | 2009 |
| fused bicyclic kinase inhibitors | 21 | 2010 |
| furo-and thieno[3,2-c] pyridines | 20 | 2008 |
| processes for the preparation of isothiazole derivatives | 18 | 2004 |
| quinazoline derivatives | 16 | 1995 |
| mtor inhibitor salt forms | 14 | 2008 |
| pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use | 12 | 2001 |